Concepedia

Kaoru Domoto

KD

Statistics

Publications

4

Citations

56

H-Index

4

Active since

2006

Affiliations

Japanese Foundation For Cancer Research(Current)

Kaoru Domoto is an author at Japanese Foundation For Cancer Research specializing in chemotherapy, oncology, and breast cancer chemotherapy.

Publications per year

2006–2010

4

Publications

4

The combination of epirubicin plus docetaxel as neoadjuvant chemotherapy in locally-advanced breast cancer.

Akira Hirano, Tadao Shimizu, Hiroshi Imamura et al. · PubMed · 2006 · 16 citations

, , +15

Common and discriminative clinicopathological features between breast cancers with pathological complete response or progressive disease in response to neoadjuvant chemotherapy

Tomo Osako, Rie Horii, Masaaki Matsuura et al. · Journal of Cancer Research and Clinical Oncology · 2009 · 15 citations · Full text

, , +17

High-grade breast cancers include both highly sensitive and highly resistant subsets to cytotoxic chemotherapy

Tomo Osako, Rie Horii, Masaaki Matsuura et al. · Journal of Cancer Research and Clinical Oncology · 2010 · 13 citations · Full text

, , +13

Epirubicin and cyclophosphamide followed by docetaxel as primary systemic chemotherapy in locally advanced breast cancer.

Akira Hirano, Tadao Shimizu, Osamu Watanabe et al. · PubMed · 2009 · 12 citations

, , +11

1–4 of 4